UPDATE: Incyte (INCY) PT Raised to $77 at Morgan Stanley After Opzelura Sales Met Expectations
Tweet Send to a Friend
(Updated - May 5, 2022 8:15 AM EDT)
Morgan Stanley analyst Vikram Purohit raised the price target on Incyte ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Vikram Purohit raised the price target on Incyte ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
